Ind-Swift Laboratories Limited reported earnings results for the fourth quarter and full year ended March 31, 2024. For the fourth quarter, the company reported sales was INR 3,933.35 million compared to INR 3,042.46 million a year ago. Revenue was INR 4,185.85 million compared to INR 314,452.6 million a year ago. Net income was INR 2,388.22 million compared to net loss of INR 251.24 million a year ago. Basic earnings per share from continuing operations was INR 40.42 compared to basic loss per share from continuing operations of INR 4.25 a year ago. Diluted earnings per share from continuing operations was INR 40.42 compared to diluted loss per share from continuing operations of INR 4.25 a year ago.

For the full year, the company reported sales was INR 12,809 million compared to INR 12,073.1 million a year ago. Revenue was INR 13,262.67 million compared to INR 12,408.1 million a year ago. Net income was INR 4,209.62 million compared to INR 475.97 million a year ago. Basic earnings per share from continuing operations was INR 71.24 compared to INR 8.06 a year ago. Diluted earnings per share from continuing operations was INR 71.24 compared to INR 8.06 a year ago.